Bone-strengthening drug gives pain relief in prostate cancer bone metastases

Stockholm, Sweden: Many prostate cancer patients develop bone metastases, and controlling the pain these cause can be difficult. Now the first large randomised Phase III trial of a bisphosphonate drug in these patients has shown that a single dose of the drug is as good for pain relief as single dose radiotherapy, the standard treatment for bone metastases. Results of the trial were presented today at the 2011 European Multidisciplinary Cancer Congress.

Read the whole article on Physorg

More from Physorg